1[1]Bowers W,Howard D and Fed eroff H:Gene therapeutic strategies for neuroprotection:implications for Parkins on′s disease.Experimental neurology 1997 ;144:56.
2[2]Carter BS,Zervas NT and Chiocca EA:Neur ogenetic surgery:current limitations and the promise of gene-and virus-based the rapies.Clinical neurosurgery 1999;45:226 .
3[3]Qureshi NH and Chiocca EA:A review of gene therapy for the treatment of centra l nervous system tumors.Oncogenesis 1999 ;10(4):261.
4[4]Karpati G,Lochmuller H,Nalbantoglu J,e t al:The principles of gene therapy for the nervous system.TINS 1996;19(2):49.
5[5]Latchman DS:Gene therapy with herpes s implex virus vectors.Archivum immunologi ae et therapiae experimentalis 1999;47:3 35.
6[6]Ho DY and Sapolsky RM:Gene therapy for the nervous system.Scientific American 1997;66:116.
7[7]Kang UJ:Potential of gene therapy for Parkinson′s disease: neurobiologic issue s and new developmen t s in gene transfer methodologies.Movemen t disorders 1998;13:59.
8[8]Costantini LC,Bakowska JC,Breakefield XO,et al:Gene therapy in the CNS.Gene th erapy 2000;7:93.
9[9]Haberman R,McCown T,Samulski R:Inducib le long-term gene expression in brain wi th adeno-associated virus gene transfer. Gene therapy 1998;5:1604.
10[10].Artinez-Serrano A and Bjorklund A:Imm ortalized neural progenitor cells for CN S gene transfer and repair.Trends in neu roscience 1997;20:530.
